Bacteriology & Antibiotics

The market is segmented on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World. At present, North America and Europe are the most prominent markets, owing to growing prevalence of various gram-positive bacterial infections and associated diseases. However, Asia-Pacific and some countries in Rest of the World region are expected to show lucrative growth in upcoming period, owing to rapidly growing prevalence and awareness about the mycobacterial diseases caused due to gram-positive bacteria and their chronic effects. Under microbiology the value of microbials market is projected to increase to $4,456.37 million by 2019 at a CAGR of 15.3% from 2014. The market is expected to show a prominent cell growth during the forecast period 2014 – 2020.